Osimertinib lung cancer drug molecule. Computer model showing the structure of a molecule of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) osimertinib, which is used to treat advanced non-small-cell lung carcinoma (NSCLC, cancer). Atoms are colour-coded: carbon (light blue), hydrogen (white), oxygen (red), nitrogen (dark blue).
Model release not required. Property release not required.